Also, no study to date has explored the correlation between galectin-9 and CXCL-13 plasma concentrations in CLL patients or compared their collaborative accuracy as prognostic biomarkers. The gene discussed is CXCL13; the disease is B-cell chronic lymphocytic leukemia.